HomeINNPD • OTCMKTS
add
Innocan Pharma Corp
Previous close
$8.24
Year range
$5.20 - $12.22
Market cap
54.02M CAD
Avg Volume
9.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 7.01M | -18.95% |
Operating expense | 5.80M | -22.33% |
Net income | -590.00K | -275.07% |
Net profit margin | -8.42 | -315.90% |
Earnings per share | — | — |
EBITDA | 405.00K | -25.28% |
Effective tax rate | -188.99% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.26M | 39.81% |
Total assets | 11.04M | 26.63% |
Total liabilities | 4.35M | 62.54% |
Total equity | 6.69M | — |
Shares outstanding | 4.50M | — |
Price to book | 8.86 | — |
Return on assets | 9.06% | — |
Return on capital | 12.16% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -590.00K | -275.07% |
Cash from operations | 686.00K | 1.63% |
Cash from investing | -2.00K | 33.33% |
Cash from financing | 153.00K | 3,160.00% |
Net change in cash | 890.00K | 49.83% |
Free cash flow | 1.29M | 6,856.76% |
About
Founded
2018
Website
Employees
8
